Stockscreener 앱 받기
2.09
2.45%
0.05
시간 외 거래:
2.09
전일 마감가:
$2.04
열려 있는:
$2.04
하루 거래량:
21,875
Relative Volume:
0.75
시가총액:
$82.45M
수익:
$57,000
순이익/손실:
$-32.14M
주가수익비율:
-3.2323
EPS:
-0.6466
순현금흐름:
$-27.58M
1주 성능:
+2.45%
1개월 성능:
+3.98%
6개월 성능:
+3.98%
1년 성능:
-33.23%
1일 변동 폭
$2.04
$2.15
1주일 범위
$2.01
$2.15
52주 변동 폭
$1.56
$3.95
Sera Prognostics Inc Stock (SERA) Company Profile
명칭
Sera Prognostics Inc
전화
(801) 990-0520
주소
2749 E. PARLEYS WAY, SALT LAKE CITY
Compare SERA vs ABT, MDT, SYK, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SERA
Sera Prognostics Inc
|
2.09 | 80.48M | 57,000 | -32.14M | -27.58M | -0.6466 |
ABT
Abbott Laboratories
|
97.50 | 175.27B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
86.38 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
275.43 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
42.60 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.15 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Sera Prognostics Inc Stock (SERA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-15 | 개시 | Jefferies | Buy |
| 2022-03-30 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-11-19 | 개시 | Oppenheimer | Outperform |
| 2021-10-15 | 재개 | Cowen | Outperform |
Sera Prognostics Inc 주식(SERA)의 최신 뉴스
Sera Prognostics, Inc.(NasdaqGM: SERA) dropped from S&P Global BMI Index - marketscreener.com
Sera Prognostics Q2 2026 Earnings: Wider-Than-Expected Loss Overshadows Modest Stock GainOperating Margin Analysis - careplusvn.com
Can Sera (SERA) Sustain Its +2.01% Momentum This Week? 2026-09-16Common Gap - dars.gov.et
SERA Prognostics General Counsel Jackson Benjamin Sells 2,190 Shares at $2 Each - kalkinemedia.com
Sera prognostics CCO Lee Jr. sells $3,600 in stock - Investing.com India
Sera prognostics CCO Lee Jr. sells $3,600 in stock By Investing.com - Investing.com South Africa
Tiffany Inglis, Sera Prognostics CMO, sells $972 in shares By Investing.com - Investing.com Australia
Sera Prognostics CEO Zhenya Lindgardt sells $14,044 in stock By Investing.com - Investing.com Australia
Tiffany Inglis, Sera Prognostics CMO, sells $972 in shares - Investing.com India
Tax-cover stock sale by Sera Prognostics (NASDAQ: SERA) general counsel - Stock Titan
Sera Prognostics (NASDAQ: SERA) insider to sell shares to cover taxes - Stock Titan
Sera Prognostics (SERA) officer to sell 486 shares for tax withholding - Stock Titan
Sera Prognostics (NASDAQ: SERA) officer to sell 2,190 shares to cover RSU taxes - Stock Titan
Sera Prognostics (NASDAQ: SERA) plans tax sell-to-cover by officer - Stock Titan
Sera Prognostics (SERA) officer plans RSU tax sale - Stock Titan
Sera Prognostics (NASDAQ: SERA) holder to sell shares to cover RSU taxes - Stock Titan
Sera Prognostics (SERA) CEO sells shares in tax-withholding trade - Stock Titan
Sera Prognostics (NASDAQ: SERA) officer to sell 13,591 shares for tax withholding - Stock Titan
Sera Prognostics Inc (NASDAQ: SERA) Share Price, SERA Stock News, SERA Share Price & Updates - kalkine.ca
Sera Prognostics (SERA) insider falls out of SEC officer status with no share trades - Stock Titan
Gleason Scott Appointed as New CFO and Insider at SERA Prognostics - Kalkine Media
Sera Prognostics (SERA) Holds Near $2.08 After Marginal 0.24% DeclineArms Index - dars.gov.et
1 in 10 U.S. Babies Are Born Too Early. A Leading OB-GYN Says Most Mothers Can Learn Their Risk by Week 21, and Do Something About It. - Eastern Progress
Sera (SERA) Earnings Report: EPS Comes in Below Forecast under the Current Snapshot; Share Move: Shares Move 1.87% Higher in the Current UpdateEPS Revision Trend - dars.gov.et
SERA | Sera Prognostics, Inc. Class FinancialsRevenue Breakdown - Quiver Quantitative
Sera Prognostics Inc (SERA) Stock News Today - TradingKey
Sera Prognostics Still Needs Revenue Proof to Match Its Clinical Momentum - AlphaStreet
Sera Prognostics (SERA) Loses 27% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Eastern Progress
Sera Prognostics names Scott Gleason as chief financial officer By Investing.com - Investing.com Australia
Form 8K Sera Prognostics Inc For: 19 August By Investing.com - Investing.com South Africa
Sera Prognostics Appoints Scott Gleason as CFO - Minichart
Sera Prognostics Announces CFO Transition and Succession Plan - TipRanks
Sera Prognostics Names Scott Gleason as CFO - marketscreener.com
Sera Prognostics, Inc. Announces CFO Changes, Effective August 31, 2026 - marketscreener.com
Sera Prognostics names Scott Gleason as chief financial officer - Investing.com
Sera Prognostics Appoints Scott Gleason Chief Financial Officer - TradingView
SERA PROGNOSTICS APPOINTS SCOTT GLEASON CHIEF FINANCIAL OFFICER – Company Announcement - Financial Times
Reported EPS Misses Expectations in the Current Update; After Earnings: Shares Finish 5.70% Up in Latest Trading - vinanet.vn
SERA PROGNOSTICS APPOINTS SCOTT GLEASON CHIEF FINANCIAL OFFICER - PR Newswire
SERA Q2 2026 Earnings: Wider-Than-Expected Loss Pressures SharesReturn On Equity - vinanet.vn
Sera Prognostics Inc. (SERA) Q2 2026 Earnings: EPS Misses Estimates as Shares Decline 2.49%Next Quarter Guidance - dars.gov.et
Sera Prognostics Earnings Call Signals Slow, Strategic Ramp - TipRanks
TD Cowen Maintains Sera Prognostics(SERA.US) With Buy Rating - Moomoo
Sera Prognostics, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
William Blair Initiates Sera Prognostics(SERA.US) With Buy Rating - Moomoo
Sera Prognostics Q2 2026 Earnings Call Transcript - MarketBeat
Sera Prognostics Q2 2026 loss widens to $9.1 million; Illinois Medicaid mandate - scanx.trade
Sera Prognostics earnings missed by $0.03, revenue fell short of estimates - Investing.com Canada
Sera Prognostics Inc (SERA) (Q2 2026) Earnings Call Highlights: Payer Momentum Builds with ... - Yahoo Finance
Sera Prognostics Q2 Earnings Call Highlights - MarketBeat
SERA Looks 10.5% Overvalued on GF Value™ - GuruFocus
Sera Prognostics Inc (SERA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Sera Prognostics Inc 주식 (SERA) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Lindgardt Zhenya | Chief Executive Officer |
Sep 10 '26 |
Sale |
2.00 |
7,022 |
14,044 |
837,848 |
| Inglis Tiffany Eul Davis | Chief Medical Officer |
Sep 10 '26 |
Sale |
2.00 |
486 |
972 |
91,589 |
| Jackson Benjamin | General Counsel |
Sep 10 '26 |
Sale |
2.00 |
2,190 |
4,380 |
159,566 |
0.26%
0.38%
자본화:
|
볼륨(24시간):